Best Practice & Research Clinical Rheumatology
Volume 25, Issue 6 , Pages 751-766 , December 2011

Emerging Frontiers in cartilage and chondrocyte biology

  • Amanda J. Fosang

      Affiliations

    • University of Melbourne, Department of Paediatrics, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville 3052, Australia
    • Corresponding Author InformationCorresponding author.
    • ,
  • Frank Beier

      Affiliations

    • Department of Physiology & Pharmacology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada

References 

  1. Thomas L. Reversible collapse of rabbit ears after intravenous papain, and prevention of recovery by cortisone. Journal of Experimental Medicine. 1956;104:245–261
  2. Pratta MA, Yao W, Decicco C, Tortorella MD, Lui RQ, Copeland RA, et al. Aggrecan protects cartilage collagen from proteolytic cleavage. Journal of Biological Chemistry. 2003;30:30
  3. Hedlund H, Hedbom E, Heinegard D, Mengarelli-Widholm S, Reinholt FP, Svensson O. Association of the aggrecan keratan sulfate-rich region with collagen in bovine articular cartilage. Journal of Biological Chemistry. 1999;274:5777–5781
  4. Maroudas AI. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature. 1976;260:808–809
  5. Maroudas A, Evans H, Almeida L. Cartilage of the hip joint. topographical variation of glycosaminoglycan content in normal and fibrillated tissue. Annals of the Rheumatic Diseases. 1973;32:1–9
  6. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. Journal of Clinical Investigation. 1994;93:1722–1732
  7. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. Journal of Clinical Investigation. 1995;96:2859–2869
  8. Little CB, Meeker CT, Golub SB, Lawlor KE, Farmer PJ, Smith SM, et al. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. Journal of Clinical Investigation. 2007;117:1627–1636
  9. Vankemmelbeke MN, Holen I, Wilson AG, Ilic MZ, Handley CJ, Kelner GS, et al. Expression and activity of ADAMTS-5 in synovium. European Journal of Biochemistry. 2001;268:1259–1268
  10. East CJ, Rogerson FM, Lawlor KE, Stanton H, Fosang AJ. In Transactions Orthopaedic Research Society. 576.
  11. Beekman B, Verzijl N, de Roos JA, TeKoppele JM. Matrix degradation by chondrocytes cultured in alginate: IL-1 beta induces proteoglycan degradation and proMMP synthesis but does not result in collagen degradation. Osteoarthritis and Cartilage. 1998;6:330–340
  12. Stoop R, van der Kraan PM, Buma P, Hollander AP, Poole AR, van den Berg WB. Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage. Jounal of Pathology. 1999;188:329–337
  13. Maroudas A, Bayliss MT, Uchitel-Kaushansky N, Schneiderman R, Gilav E. Aggrecan turnover in human articular cartilage: use of aspartic acid racemization as a marker of molecular age. Archives of Biochemistry and Biophysics. 1998;350:61–71
  14. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. Journal of Biological Chemistry. 2000;275:39027–39031
  15. Milner JM, Elliott SF, Cawston TE. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Arthritis and Rheumatism. 2001;44:2084–2096
  16. Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB. Activation of cartilage matrix metalloproteinases by activated protein C. Arthritis and Rheumatism. 2009;60:780–791
  17. Milner JM, Patel A, Davidson RK, Swingler TE, Desilets A, Young DA, et al. Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis. Arthritis and Rheumatism. 2010;62:1955–1966
  18. Milner JM, Patel A, Rowan AD. Emerging roles of serine proteinases in tissue turnover in arthritis. Arthritis and Rheumatism. 2008;58:3644–3656
  19. Jin X, Yagi M, Akiyama N, Hirosaki T, Higashi S, Lin CY, et al. Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sciences. 2006;97:1327–1334
  20. Oberst MD, Singh B, Ozdemirli M, Dickson RB, Johnson MD, Lin CY. Characterization of matriptase expression in normal human tissues. Journal of Histochemistry Cytochemistry. 2003;51:1017–1025
  21. Oberst MD, Williams CA, Dickson RB, Johnson MD, Lin CY. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. Journal of Biological Chemistry. 2003;278:26773–26779
  22. Dahlback B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Letters. 2005;579:3310–3316
  23. Knäuper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. Journal of Biological and Chemistry. 1997;272:7608–7616
  24. Gotis-Graham I, McNeil HP. Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis and Rheumatism. 1997;40:479–489
  25. Gotis-Graham I, Smith MD, Parker A, McNeil HP. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Annals of the Rheumatic Diseases. 1998;57:664–671
  26. Tetlow LC, Woolley DE. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Annals of the Rheumatic Diseases. 1995;54:896–903
  27. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. European Journal of Biochemistry. 1994;223:171–177
  28. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. Journal of Biological Chemistry. 1994;269:18134–18140
  29. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. Journal of Clinical Investigation. 1989;84:1657–1662
  30. Gruber BL, Schwartz LB, Ramamurthy NS, Irani AM, Marchese MJ. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. Journal of Immunology. 1988;140:3936–3942
  31. Lawlor KE, Campbell IK, O'Donnell K, Wu L, Wicks IP. Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. Arthritis and Rheumatism. 2001;44:442–450
  32. McNeil HP, Shin K, Campbell IK, Wicks IP, Adachi R, Lee DM, et al. The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. Arthritis and Rheumatism. 2008;58:2338–2346
  33. Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. Journal of Immunology. 2009;182:647–656
  34. Seidah NG, Mayer G, Zaid A, Rousselet E, Nassoury N, Poirier S, et al. The activation and physiological functions of the proprotein convertases. International Journal of Biochemistry Cellular Biology. 2008;40:1111–1125
  35. Vidricaire G, Denault JB, Leduc R. Characterization of a secreted form of human furin endoprotease. Biochemical Biophysics Research Communications. 1993;195:1011–1018
  36. Koo BH, Apte SS. Cell-surface processing of pro-ADAMTS9 by furin. Journal of Biological Chemistry. 2006;281:12485–12494
  37. Tortorella MD, Arner EC, Hills R, Gormley J, Fok K, Pegg L, et al. ADAMTS-4 (aggrecanase-1): N-Terminal activation mechanisms. Archives of Biochemistry and Biophysics. 2005;444:34–44
  38. Longpre JM, McCullogh DR, Koo BH, Alexander JP, Apte SS, Leduc R, et al. Characterization of proADAMTS5 processing by proprotein convertases. International Journal of Biochemistry and Cell Biology. 2009;41:1116–1126
  39. Malfait AM, Arner EC, Song RH, Alston JT, Markosyan S, Staten N, et al. Proprotein convertase activation of aggrecanases in cartilage in situ. Archives of Biochemistry and Biophysics. 2008;478:43–51
  40. Goldring MB, Goldring SR. Osteoarthritis. Journal of Cell Physiology. 2007;213:626–634
  41. Aigner T, Haag J, Martin J, Buckwalter J. Osteoarthritis: aging of matrix and cells–going for a remedy. Current Drug Targets. 2007;8:325–331
  42. Ballock RT, O'Keefe RJ. Physiology and pathophysiology of the growth plate. Birth Defects Research, Part C, Embryo Today: Reviews. 2003;69:123–143
  43. Beier F. Cell-cycle control and the cartilage growth plate. Journal of Cell Physiology. 2005;202:1–8
  44. Kronenberg HM. Developmental regulation of the growth plate. Nature. 2003;423:332–336
  45. Woods A, Wang G, Beier F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. Journal of Cell Physiology. 2007;213:1–8
  46. Chung UI. Essential role of hypertrophic chondrocytes in endochondral bone development. Endocrine Journal. 2004;51:19–24
  47. Hyde G, Dover S, Aszodi A, Wallis GA, Boot-Handford RP. Lineage tracing using matrilin-1 gene expression reveals that articular chondrocytes exist as the joint interzone forms. Developmental Biology. 2007;304:825–833
  48. Koyama E, Shibukawa Y, Nagayama M, Sugito H, Young B, Yuasa T, et al. A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Developmental Biology. 2008;316:62–73
  49. Freyria AM, Mallein-Gerin F. Chondrocytes or adult stem cells for cartilage repair: The indisputable role of growth factors. Injury. 2011;
  50. Aigner T, Reichenberger E, Bertling W, Kirsch T, Stoss H, von der Mark K. Type X collagen expression in osteoarthritic and rheumatoid articular cartilage. Virchows Archive B: Cell Pathology Including Molecular Pathology. 1993;63:205–211
  51. Cecil DL, Appleton CT, Polewski MD, Mort JS, Schmidt AM, Bendele A, et al. The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli. Journal of Immunology. 2009;182:5024–5031
  52. Pullig O, Weseloh G, Ronneberger D, Kakonen S, Swoboda B. Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcified Tissue International. 2000;67:230–240
  53. Hoyland JA, Thomas JT, Donn R, Marriott A, Ayad S, Boot-Handford RP, et al. Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone and Mineral. 1991;15:151–163
  54. Appleton CT, McErlain DD, Pitelka V, Schwartz N, Bernier SM, Henry JL, et al. Forced mobilization accelerates pathogenesis: Characterization of a pre-clinical surgical model of osteoarthritis. Arthritis Research Therapy. 2007;9:R13
  55. Fuerst M, Bertrand J, Lammers L, Dreier R, Echtermeyer F, Nitschke Y, et al. Calcification of articular cartilage in human osteoarthritis. Arthritis and Rheumatism. 2009;60:2694–2703
  56. Kamekura S, Kawasaki Y, Hoshi K, Shimoaka T, Chikuda H, Maruyama Z, et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis and Rheumatism. 2006;54:2462–2470
  57. Hirata M, Kugimiya F, Fukai A, Ohba S, Kawamura N, Ogasawara T, et al. C/EBPbeta Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS ONE. 2009;4:e4543
  58. Yang S, Kim J, Ryu JH, Oh H, Chun CH, Kim BJ, et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nature Medicine. 2010;16:687–693
  59. Saito T, Fukai A, Mabuchi A, Ikeda T, Yano F, Ohba S, et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nature Medicine. 2010;16:678–686
  60. Liu-Bryan R, Terkeltaub R. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis and Rheumatism. 2010;62:2004–2012
  61. Merz D, Liu R, Johnson K, Terkeltaub R. IL-8/CXCL8 and Growth-Related Oncogene {alpha}/CXCL1 Induce hondrocyte hypertrophic differentiation. Journal of Immunology. 2003;171:4406–4415
  62. Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R. Inflammation-Induced Chondrocyte hypertrophy is Driven by receptor for advanced glycation end products. Journal of Immunology. 2005;175:8296–8302
  63. Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, et al. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis and Rheumatism. 2000;43:664–672
  64. Wu CW, Tchetina EV, Mwale F, Hasty K, Pidoux I, Reiner A, et al. Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization. Journal of Bone and Mineral Research. 2002;17:639–651
  65. Todhunter PG, Kincaid SA, Todhunter RJ, Kammermann JR, Johnstone B, Baird AN, et al. Immunohistochemical analysis of an equine model of synovitis-induced arthritis. American Journal of Veterinary Research. 1996;57:1080–1093
  66. Pitsillides AA, Beier F. Cartilage biology in osteoarthritis - lessons from developmental biology. Nature Reviews Rheumatology. 2011;7:654–663
  67. Dreier R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Research Therapy. 2010;12:216
  68. Blom AB, van Lent PL, van der Kraan PM, van den Berg WB. To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy. Current Drug Targets. 2010;11:620–629
  69. Lin AC, et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nature Medicine. 2009;15:1421–1425
  70. Serra R, et al. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. Journal of Cell Biology. 1997;139:541–552
  71. Yang X, et al. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. Journal of Cell Biology. 2001;153:35–46
  72. van der Kraan PM, Goumans MJ, Blaney Davidson E, Ten Dijke P. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Research. 2011;
  73. Finnson KW, et al. Endoglin differentially regulates TGF-beta-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage. 2010;18:1518–1527
  74. Iwamoto M, et al. The role of ERG (ets related gene) in cartilage development. Osteoarthritis Cartilage. 2001;9(Suppl A):S41–S47
  75. Iwamoto M, et al. Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. Journal Cell Biology. 2000;150:27–40
  76. Iwamoto M, Tamamura Y, Koyama E, Komori T, Takeshita N, Williams JA, et al. Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis. Developmental Biology. 2007;305:40–51
  77. Hardingham TE. Fell-Muir lecture: cartilage 2010-the known unknowns. International Journal of Experimental Pathology. 2010;91:203–209
  78. Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell. 1979;17:771–779
  79. Cheung JO, Hillarby MC, Ayad S, Hoyland JA, Jones CJ, Denton J, et al. A novel cell culture model of chondrocyte differentiation during mammalian endochondral ossification. Journal of Bone Mineral Research. 2001;16:309–318
  80. Roach HI, Aigner T. DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthritis and Cartilage. 2007;15:128–137
  81. Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Annals of the Rheumatic Diseases. 2010;69:1502–1510
  82. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis and Rheumatism. 2005;52:3110–3124
  83. Loeser RF, Im HJ, Richardson B, Lu Q, Chubinskaya S. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis and Cartilage. 2009;17:513–517
  84. Cheung KS, Hashimoto K, Yamada N, Roach HI. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatology International. 2009;29:525–534
  85. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell. 2004;119:555–566
  86. Williams SR, Aldred MA, Der Kaloustian VM, Halal F, Gowans G, McLeod DR, et al. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. American Journal of Human Genetics. 2010;87:219–228
  87. Fujita N, Matsushita T, Ishida K, Kubo S, Matsumoto T, Takayama K, et al. Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through the modulation of chondrocyte gene expressions. Journal of Orthopaedic Research. 2011;29:511–515
  88. Gagarina V, Gabay O, Dvir-Ginzberg M, Lee EJ, Brady JK, Quon MJ, et al. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis and Rheumatism. 2010;62:1383–1392
  89. Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis and Rheumatism. 2009;60:2731–2740
  90. Dvir-Ginzberg M, Gagarina V, Lee EJ, Hall DJ. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. Journal of Biological Chemistry. 2008;283:36300–36310
  91. Dvir-Ginzberg M, Gagarina V, Lee EJ, Booth R, Gabay O, Hall DJ. Tumor necrosis factor alpha-mediated cleavage and inactivation of sirT1 in human osteoarthritic chondrocytes. Arthritis and Rheumatism. 2011;63:2363–2373
  92. Hong EH, Yun HS, Kim J, Um HD, Lee KH, Kang CM, et al. Nicotinamide Phosphoribosyltransferase s Essential for Interleukin-1{beta}-mediated dedifferentiation of articular chondrocytes via SIRT1 and extracellular Signal-regulated kinase (ERK) complex signaling. Journal of Biological Chemistry. 2011;286:28619–28631
  93. Kobayashi T, Lu J, Cobb BS, Rodda SJ, Mc Mahon AP, Schipani E, et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proceedings of National of of Acadamic Sciences U S A. 2008;105:1949–1954
  94. Miyaki S, Nakasa T, Otsuki S, Grogan SP, Higashiyama R, Inoue A, et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis and Rheumatism. 2009;60:2723–2730
  95. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I, et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Letters. 2006;580:4214–4217
  96. Yang J, Qin S, Yi C, Ma G, Zhu H, Zhou W, et al. MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Letters. 2011;585:2992–2997
  97. Nakamura Y, Inloes JB, Katagiri T, Kobayashi T. Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Molecular Cellular Biology. 2011;31:3019–3028
  98. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes and Development. 2010;24:1173–1185
  99. Tardif G, Hum D, Pelletier JP, Duval N, Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskeletal Disorders. 2009;10:148
  100. Li X, Gibson G, Kim JS, Kroin J, Xu S, van Wijnen AJ, et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene. 2011;480:34–41
  101. Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, Adachi N, et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis and Rheumatism. 2009;60:1035–1041
  102. Nakasa T, Nagata Y, Yamasaki K, Ochi M. A mini-review: microRNA in arthritis. Physiology Genomics. 2011;43:566–570
  103. Wittmann J, Jack HM. microRNAs in rheumatoid arthritis: midget RNAs with a giant impact. Annals of the Rheumatic Diseases. 2011;70(Suppl. 1):i92–i96
  104. Ceribelli A, Yao B, Dominquez-Gutierrez PR, Nahid MA, Satoh M, Chan EK. MicroRNAs in systemic rheumatic diseases. Arthritis Research Therapy. 2011;13:229
  105. Appleton CT, Pitelka V, Henry J, Beier F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis and Rheumatism. 2007;56:1854–1868
  106. Appleton CTG, Usmani SE, Bernier SM, Aigner T, Beier F. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis and Rheumatism. 2007;56:3693–3705
  107. Hallbeck AL, Walz TM, Briheim K, Wasteson A. TGF-alpha and ErbB2 production in synovial joint tissue: increased expression in arthritic joints. Scandinavian Journal of Rheumatology. 2005;34:204–211
  108. Appleton CT, Usmani SE, Mort JS, Beier F. Rho/ROCK and MEK/ERK activation by transforming growth factor-alpha induces articular cartilage degradation. Laboratory Investigation. 2010;90:20–30
  109. Koga H, Engebretsen L, Brinchmann JE, Muneta T, Sekiya I. Mesenchymal stem cell-based therapy for cartilage repair: a review. Knee Surg Sports Traumatology Arthroscopy. 2009;17:1289–1297
  110. Brittberg M, Lindahl A, Nillson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New England Journal of Medicine. 1994;331:889–895
  111. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clinical Orthopaedics and Related Research. 1980;294-307:
  112. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exprimental Hematology. 1976;4:267–274
  113. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell and Tissue Research. 2007;327:449–462
  114. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells. 2007;25:750–760
  115. Park J, Gelse K, Frank S, von der Mark K, Aigner T, Schneider H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells. Journal of Gene Medicine. 2006;8:112–125
  116. Koga H, Muneta T, Nagase T, Nimura A, Jun YJ, Mochizuki T, et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Research. 2008;333:207–215
  117. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental Cell Research. 1998;238:265–272
  118. Guo X, Zheng Q, Yang S, Shao Z, Yuan Q, Pan Z, et al. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene. Biomedical Materials. 2006;1:206–215
  119. Gao J, Yao JQ, Caplan AI. Stem cells for tissue engineering of articular cartilage. Proceedings of the Institution of Mechanical Engineers H. 2007;221:441–450
  120. Mendelson A, Frank E, Allred C, Jones E, Chen M, Zhao W, et al. Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro. Faseb Journal. 2011;
  121. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Research. 2005;320:269–276
  122. Nawata M, Wakitani S, Nakaya H, Tanigami A, Seki T, Nakamura Y, et al. Use of bone morphogenetic protein 2 and diffusion chambers to engineer cartilage tissue for the repair of defects in articular cartilage. Arthritis and Rheumatism. 2005;52:155–163
  123. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC. Spontaneous human adult stem cell transformation. Cancer Research. 2005;65:3035–3039
  124. Kandel RA, Grynpas M, Pilliar R, Lee J, Wang J, Waldman S, et al. Repair of osteochondral defects with biphasic cartilage-calcium polyphosphate constructs in a sheep model. Biomaterials. 2006;27:4120–4131
  125. Moutos FT, Freed LE, Guilak F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nature Materials. 2007;6:162–167
  126. Moutos FT, Estes BT, Guilak F. Multifunctional hybrid three-dimensionally woven scaffolds for cartilage tissue engineering. Macromolucular Bioscience. 2010;10:1355–1364
  127. Koga H, Shimaya M, Muneta T, Nimura A, Morito T, Hayashi M, et al. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Research Therapy. 2008;10:R84
  128. Ando W, Tateishi K, Hart DA, Katakai D, Tanaka Y, Nakata K, et al. Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials. 2007;28:5462–5470
  129. Lee CH, Cook JL, Mendelson A, Moioli EK, Yao H, Mao JJ. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet. 2010;376:440–448

PII: S1521-6942(11)00161-6

doi: 10.1016/j.berh.2011.11.010

Best Practice & Research Clinical Rheumatology
Volume 25, Issue 6 , Pages 751-766 , December 2011

Article Tools

* Image Usage & Resolution